

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80642848 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17540743 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17540743 |
| 4 | regulation of female gonad development (GO:2000194) | 3.82768993 |
| 5 | histone H2A monoubiquitination (GO:0035518) | 3.78007133 |
| 6 | positive regulation of histone deacetylation (GO:0031065) | 3.68264942 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.67426699 |
| 8 | regulation of histone H3-K27 methylation (GO:0061085) | 3.62723089 |
| 9 | regulation of RIG-I signaling pathway (GO:0039535) | 3.51346960 |
| 10 | megakaryocyte development (GO:0035855) | 3.49976710 |
| 11 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.38225461 |
| 12 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.35808662 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33174247 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30702883 |
| 15 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.29593749 |
| 16 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.24796656 |
| 17 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.18148345 |
| 18 | regulation of histone phosphorylation (GO:0033127) | 3.14042984 |
| 19 | histone H2A ubiquitination (GO:0033522) | 3.07846493 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.07358660 |
| 21 | regulation of sister chromatid cohesion (GO:0007063) | 3.05200273 |
| 22 | protein localization to kinetochore (GO:0034501) | 3.05164337 |
| 23 | mannose metabolic process (GO:0006013) | 3.00011364 |
| 24 | carnitine shuttle (GO:0006853) | 2.99132069 |
| 25 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96862760 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 2.96678358 |
| 27 | lysine metabolic process (GO:0006553) | 2.92305485 |
| 28 | lysine catabolic process (GO:0006554) | 2.92305485 |
| 29 | fatty acid transmembrane transport (GO:1902001) | 2.89240790 |
| 30 | regulation of meiosis (GO:0040020) | 2.89175070 |
| 31 | citrulline biosynthetic process (GO:0019240) | 2.85358048 |
| 32 | mitotic chromosome condensation (GO:0007076) | 2.83809664 |
| 33 | urea cycle (GO:0000050) | 2.82714615 |
| 34 | urea metabolic process (GO:0019627) | 2.82714615 |
| 35 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.82452659 |
| 36 | regulation of early endosome to late endosome transport (GO:2000641) | 2.81743607 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81476338 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.79350808 |
| 39 | negative regulation of cell size (GO:0045792) | 2.75875527 |
| 40 | regulation of granulocyte differentiation (GO:0030852) | 2.75240608 |
| 41 | female gamete generation (GO:0007292) | 2.75020484 |
| 42 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.73062327 |
| 43 | regulation of sequestering of triglyceride (GO:0010889) | 2.72543874 |
| 44 | valine metabolic process (GO:0006573) | 2.71958317 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70321404 |
| 46 | angiogenesis involved in wound healing (GO:0060055) | 2.69895361 |
| 47 | regulation of Rap GTPase activity (GO:0032317) | 2.69401350 |
| 48 | positive regulation of protein deacetylation (GO:0090312) | 2.68664212 |
| 49 | negative regulation of necroptotic process (GO:0060546) | 2.67757751 |
| 50 | diacylglycerol metabolic process (GO:0046339) | 2.67443936 |
| 51 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.66272886 |
| 52 | detection of calcium ion (GO:0005513) | 2.66126113 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65708632 |
| 54 | DNA damage induced protein phosphorylation (GO:0006975) | 2.65279977 |
| 55 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.64741306 |
| 56 | glycerophospholipid catabolic process (GO:0046475) | 2.64154985 |
| 57 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.63452062 |
| 58 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.62325869 |
| 59 | phospholipid dephosphorylation (GO:0046839) | 2.61709762 |
| 60 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.60715914 |
| 61 | myelin maintenance (GO:0043217) | 2.60544350 |
| 62 | creatine metabolic process (GO:0006600) | 2.59882685 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 2.58420986 |
| 64 | regulation of fatty acid oxidation (GO:0046320) | 2.58371014 |
| 65 | protein localization to chromosome, centromeric region (GO:0071459) | 2.57801188 |
| 66 | alpha-linolenic acid metabolic process (GO:0036109) | 2.57489393 |
| 67 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.56121650 |
| 68 | epithelial cell fate commitment (GO:0072148) | 2.55527410 |
| 69 | cardiac myofibril assembly (GO:0055003) | 2.55111971 |
| 70 | type B pancreatic cell development (GO:0003323) | 2.54411073 |
| 71 | T cell migration (GO:0072678) | 2.52348009 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 2.51611254 |
| 73 | regulation of necroptotic process (GO:0060544) | 2.50786644 |
| 74 | maturation of 5.8S rRNA (GO:0000460) | 2.50134596 |
| 75 | T cell apoptotic process (GO:0070231) | 2.49702118 |
| 76 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.49677944 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 2.47965423 |
| 78 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.47489043 |
| 79 | potassium ion import (GO:0010107) | 2.46329050 |
| 80 | positive thymic T cell selection (GO:0045059) | 2.45632069 |
| 81 | negative regulation of hormone metabolic process (GO:0032351) | 2.45292910 |
| 82 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.45292910 |
| 83 | regulation of exit from mitosis (GO:0007096) | 2.45131261 |
| 84 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.43495511 |
| 85 | NADH metabolic process (GO:0006734) | 2.43224876 |
| 86 | regulation of B cell differentiation (GO:0045577) | 2.42979331 |
| 87 | positive regulation of fatty acid oxidation (GO:0046321) | 2.42402266 |
| 88 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.41874595 |
| 89 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.41776992 |
| 90 | positive regulation of sodium ion transport (GO:0010765) | 2.41563233 |
| 91 | regulation of extracellular matrix disassembly (GO:0010715) | 2.41515953 |
| 92 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41400940 |
| 93 | positive regulation of Rap GTPase activity (GO:0032854) | 2.40682108 |
| 94 | inositol phosphate catabolic process (GO:0071545) | 2.40413027 |
| 95 | inositol phosphate dephosphorylation (GO:0046855) | 2.39809002 |
| 96 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.39809002 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39643978 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.39640292 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.39640292 |
| 100 | protein-lipid complex assembly (GO:0065005) | 2.38937531 |
| 101 | regulation of integrin activation (GO:0033623) | 2.38236072 |
| 102 | positive regulation of lamellipodium assembly (GO:0010592) | 2.37726957 |
| 103 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.37685991 |
| 104 | macroautophagy (GO:0016236) | 2.37158834 |
| 105 | negative regulation of meiosis (GO:0045835) | 2.36272430 |
| 106 | maternal placenta development (GO:0001893) | 2.35461360 |
| 107 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.34413549 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.32969896 |
| 109 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.32898107 |
| 110 | cardiac muscle adaptation (GO:0014887) | 2.31997077 |
| 111 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.31997077 |
| 112 | muscle hypertrophy in response to stress (GO:0003299) | 2.31997077 |
| 113 | mRNA stabilization (GO:0048255) | 2.31829840 |
| 114 | RNA stabilization (GO:0043489) | 2.31829840 |
| 115 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.31535831 |
| 116 | cardiac muscle hypertrophy (GO:0003300) | 2.29731941 |
| 117 | phenol-containing compound catabolic process (GO:0019336) | 2.29245501 |
| 118 | glandular epithelial cell development (GO:0002068) | 2.28650073 |
| 119 | one-carbon metabolic process (GO:0006730) | 2.28587439 |
| 120 | regulation of erythrocyte differentiation (GO:0045646) | 2.28440219 |
| 121 | heme biosynthetic process (GO:0006783) | 2.28412574 |
| 122 | protein localization to endosome (GO:0036010) | 2.27782118 |
| 123 | oocyte maturation (GO:0001556) | 2.27140003 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.27063661 |
| 125 | positive regulation of protein dephosphorylation (GO:0035307) | 2.26111025 |
| 126 | mast cell activation involved in immune response (GO:0002279) | 2.25947441 |
| 127 | mast cell degranulation (GO:0043303) | 2.25947441 |
| 128 | regulation of ARF protein signal transduction (GO:0032012) | 2.25665921 |
| 129 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24504551 |
| 130 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.24275315 |
| 131 | regulation of proton transport (GO:0010155) | 2.24225110 |
| 132 | positive regulation of lamellipodium organization (GO:1902745) | 2.24129326 |
| 133 | regulation of cholesterol storage (GO:0010885) | 2.23700306 |
| 134 | L-phenylalanine metabolic process (GO:0006558) | 2.23299617 |
| 135 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.23299617 |
| 136 | positive regulation of protein homooligomerization (GO:0032464) | 2.23133948 |
| 137 | growth hormone receptor signaling pathway (GO:0060396) | 2.22733646 |
| 138 | dendritic spine morphogenesis (GO:0060997) | 2.21075017 |
| 139 | regulation of protein glycosylation (GO:0060049) | 2.20819356 |
| 140 | skeletal muscle contraction (GO:0003009) | 2.19436927 |
| 141 | striated muscle contraction (GO:0006941) | 2.17919891 |
| 142 | myofibril assembly (GO:0030239) | 2.17825549 |
| 143 | nitric oxide mediated signal transduction (GO:0007263) | 2.17752743 |
| 144 | muscle hypertrophy (GO:0014896) | 2.17698268 |
| 145 | striated muscle hypertrophy (GO:0014897) | 2.17170246 |
| 146 | positive regulation of gluconeogenesis (GO:0045722) | 2.15083702 |
| 147 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.14328340 |
| 148 | response to acidic pH (GO:0010447) | 2.13621738 |
| 149 | cardiac muscle contraction (GO:0060048) | 2.10853341 |
| 150 | regulation of sodium ion transport (GO:0002028) | 2.10694233 |
| 151 | regulation of the force of heart contraction (GO:0002026) | 2.09221426 |
| 152 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.08629358 |
| 153 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.07989439 |
| 154 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.07133074 |
| 155 | striated muscle adaptation (GO:0014888) | 2.06216421 |
| 156 | regulation of skeletal muscle contraction (GO:0014819) | 2.04744543 |
| 157 | cardiac conduction (GO:0061337) | 2.04123064 |
| 158 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.02963410 |
| 159 | actin-myosin filament sliding (GO:0033275) | 2.02519801 |
| 160 | muscle filament sliding (GO:0030049) | 2.02519801 |
| 161 | thymic T cell selection (GO:0045061) | 2.01343096 |
| 162 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.01006440 |
| 163 | long term synaptic depression (GO:0060292) | 1.99887352 |
| 164 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.99004471 |
| 165 | positive regulation of digestive system process (GO:0060456) | 1.98715560 |
| 166 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.98426975 |
| 167 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.98383503 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 1.97690978 |
| 169 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.97046773 |
| 170 | negative regulation of protein kinase B signaling (GO:0051898) | 1.96940970 |
| 171 | one-carbon compound transport (GO:0019755) | 1.96831617 |
| 172 | dicarboxylic acid biosynthetic process (GO:0043650) | 1.96743537 |
| 173 | positive T cell selection (GO:0043368) | 1.96038885 |
| 174 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 1.95508179 |
| 175 | glycogen catabolic process (GO:0005980) | 1.95019132 |
| 176 | skeletal muscle adaptation (GO:0043501) | 1.94506112 |
| 177 | activation of MAPKKK activity (GO:0000185) | 1.93289209 |
| 178 | regulation of cholesterol metabolic process (GO:0090181) | 1.92518816 |
| 179 | positive regulation of synapse maturation (GO:0090129) | 1.89785888 |
| 180 | regulation of actin filament-based movement (GO:1903115) | 1.89699772 |
| 181 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 1.89582342 |
| 182 | cellular ketone body metabolic process (GO:0046950) | 1.89298450 |
| 183 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 1.89216116 |
| 184 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.88166804 |
| 185 | regulation of ARF GTPase activity (GO:0032312) | 1.87911458 |
| 186 | amino-acid betaine transport (GO:0015838) | 1.86955499 |
| 187 | carnitine transport (GO:0015879) | 1.86955499 |
| 188 | cellular potassium ion homeostasis (GO:0030007) | 1.86364075 |
| 189 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 1.86078205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40179257 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.29193752 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.14658787 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89144849 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.85480441 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77699472 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76038527 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64918812 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.63198107 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46013232 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45068834 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.25191844 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20973194 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.16883323 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12373476 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11689272 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10872059 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09183582 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.06560704 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.06023181 |
| 21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.03035921 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01975746 |
| 23 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.98253222 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95286347 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93078248 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89911706 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89113867 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85841638 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84988144 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84455952 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84057980 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82114553 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.81206768 |
| 34 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75748247 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72170870 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68847548 |
| 37 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68643350 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.68089045 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67379745 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67260792 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66464235 |
| 42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65060373 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63946517 |
| 44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60146190 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59745769 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57073979 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.56449775 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55891404 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55415833 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50324619 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48197319 |
| 52 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48090557 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47148708 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46724935 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45928415 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.45771631 |
| 57 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.44976945 |
| 58 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44645632 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44382745 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44195280 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.44127667 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43800768 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43307226 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43164523 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42677919 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.41854409 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38467656 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38313698 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37403619 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.36343865 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34371611 |
| 72 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33900490 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33859568 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33078764 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32518067 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31891665 |
| 77 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31245206 |
| 78 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.30235592 |
| 79 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30151868 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29808759 |
| 81 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29094419 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27395158 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27340933 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.27315026 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25643905 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25624301 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22571378 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22021127 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21650201 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.20456340 |
| 91 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19203575 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17551381 |
| 93 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17531903 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16329217 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15197403 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15016602 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14818298 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13882776 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13720343 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13436850 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.13115449 |
| 102 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12397133 |
| 103 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.11371049 |
| 104 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11364230 |
| 105 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09810294 |
| 106 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.09158073 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09131117 |
| 108 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09117543 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07953991 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07913028 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06978161 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06576571 |
| 113 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06045964 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05274640 |
| 115 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04098628 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03592653 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02876207 |
| 118 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02495694 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02428795 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02223473 |
| 121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01859504 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01224629 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97762452 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97762452 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97635137 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96942356 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.96102554 |
| 128 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95794877 |
| 129 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95779220 |
| 130 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95675882 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95616957 |
| 132 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95393308 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.94956506 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94751904 |
| 135 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94345723 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93049674 |
| 137 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92896343 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92606330 |
| 139 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92526813 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92473218 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92097445 |
| 142 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91519821 |
| 143 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91489130 |
| 144 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90798461 |
| 145 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90709472 |
| 146 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90630935 |
| 147 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89981858 |
| 148 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89727591 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89220731 |
| 150 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89006722 |
| 151 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86555664 |
| 152 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86096084 |
| 153 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86096084 |
| 154 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85908042 |
| 155 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85460435 |
| 156 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85375411 |
| 157 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85279133 |
| 158 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85264182 |
| 159 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85250419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.61216510 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.17362636 |
| 3 | MP0005451_abnormal_body_composition | 3.13361471 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.08229222 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.75005161 |
| 6 | MP0002254_reproductive_system_inflammat | 2.51821086 |
| 7 | MP0009840_abnormal_foam_cell | 2.49858453 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.32862710 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.30683798 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.24627370 |
| 11 | MP0004043_abnormal_pH_regulation | 2.24237478 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.24189003 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.18962971 |
| 14 | MP0000566_synostosis | 2.18613538 |
| 15 | MP0005360_urolithiasis | 2.16178523 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.11213517 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.09544680 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.06718353 |
| 19 | MP0004130_abnormal_muscle_cell | 1.96215198 |
| 20 | MP0004510_myositis | 1.94152534 |
| 21 | MP0003303_peritoneal_inflammation | 1.93577673 |
| 22 | MP0003045_fibrosis | 1.93411679 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.89278623 |
| 24 | MP0005365_abnormal_bile_salt | 1.79378009 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.74227749 |
| 26 | MP0000685_abnormal_immune_system | 1.71883379 |
| 27 | MP0003879_abnormal_hair_cell | 1.70236313 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.69324217 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.69324217 |
| 30 | MP0003787_abnormal_imprinting | 1.66586680 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.66580752 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.64542747 |
| 33 | MP0002653_abnormal_ependyma_morphology | 1.63380006 |
| 34 | MP0000343_altered_response_to | 1.61420253 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.60534744 |
| 36 | MP0002933_joint_inflammation | 1.58992368 |
| 37 | MP0003690_abnormal_glial_cell | 1.55895710 |
| 38 | MP0005535_abnormal_body_temperature | 1.54008441 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.53659736 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.52700184 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.52651832 |
| 42 | MP0009278_abnormal_bone_marrow | 1.51830087 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.50445404 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.46498214 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.46383473 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.44524293 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.44023345 |
| 48 | MP0003436_decreased_susceptibility_to | 1.41521818 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.41422326 |
| 50 | MP0002398_abnormal_bone_marrow | 1.39035248 |
| 51 | MP0000609_abnormal_liver_physiology | 1.37881273 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.37776217 |
| 53 | MP0003252_abnormal_bile_duct | 1.35964484 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.35305424 |
| 55 | MP0002269_muscular_atrophy | 1.33646122 |
| 56 | MP0000490_abnormal_crypts_of | 1.33549402 |
| 57 | MP0000751_myopathy | 1.31851465 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.31081254 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.28312453 |
| 60 | MP0002064_seizures | 1.27217094 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.27033889 |
| 62 | MP0000749_muscle_degeneration | 1.26956623 |
| 63 | MP0004036_abnormal_muscle_relaxation | 1.26450072 |
| 64 | MP0001800_abnormal_humoral_immune | 1.24555206 |
| 65 | MP0005423_abnormal_somatic_nervous | 1.20905239 |
| 66 | MP0003111_abnormal_nucleus_morphology | 1.20678212 |
| 67 | MP0001835_abnormal_antigen_presentation | 1.20414894 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.19138401 |
| 69 | MP0003880_abnormal_central_pattern | 1.18773880 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.18399195 |
| 71 | MP0001915_intracranial_hemorrhage | 1.18045435 |
| 72 | MP0004270_analgesia | 1.18044750 |
| 73 | MP0002405_respiratory_system_inflammati | 1.16424174 |
| 74 | MP0003077_abnormal_cell_cycle | 1.15111338 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.14812041 |
| 76 | MP0002693_abnormal_pancreas_physiology | 1.14457548 |
| 77 | MP0003699_abnormal_female_reproductive | 1.13693641 |
| 78 | MP0005310_abnormal_salivary_gland | 1.13553595 |
| 79 | MP0004084_abnormal_cardiac_muscle | 1.11567720 |
| 80 | MP0004484_altered_response_of | 1.11494542 |
| 81 | MP0002106_abnormal_muscle_physiology | 1.11432201 |
| 82 | MP0002722_abnormal_immune_system | 1.11024427 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.10182432 |
| 84 | MP0009745_abnormal_behavioral_response | 1.09738287 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.09305226 |
| 86 | MP0002971_abnormal_brown_adipose | 1.09024751 |
| 87 | MP0003718_maternal_effect | 1.08978387 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.08795676 |
| 89 | MP0001944_abnormal_pancreas_morphology | 1.07894001 |
| 90 | MP0001661_extended_life_span | 1.07843143 |
| 91 | MP0004859_abnormal_synaptic_plasticity | 1.06526793 |
| 92 | MP0000716_abnormal_immune_system | 1.06487447 |
| 93 | MP0009643_abnormal_urine_homeostasis | 1.06351438 |
| 94 | MP0005670_abnormal_white_adipose | 1.05946336 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 1.05899679 |
| 96 | MP0002429_abnormal_blood_cell | 1.05069426 |
| 97 | MP0002452_abnormal_antigen_presenting | 1.05050899 |
| 98 | MP0002420_abnormal_adaptive_immunity | 1.03298836 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 1.01946584 |
| 100 | MP0008569_lethality_at_weaning | 1.01123836 |
| 101 | MP0002419_abnormal_innate_immunity | 1.01031748 |
| 102 | MP0010094_abnormal_chromosome_stability | 1.00901892 |
| 103 | MP0001819_abnormal_immune_cell | 1.00642640 |
| 104 | MP0005330_cardiomyopathy | 0.99580973 |
| 105 | MP0005448_abnormal_energy_balance | 0.99364251 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.98778768 |
| 107 | MP0002970_abnormal_white_adipose | 0.98755707 |
| 108 | MP0009115_abnormal_fat_cell | 0.98585730 |
| 109 | MP0002723_abnormal_immune_serum | 0.97942057 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97853327 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.97667227 |
| 112 | MP0000598_abnormal_liver_morphology | 0.97635611 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.97352541 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.97141837 |
| 115 | MP0005369_muscle_phenotype | 0.96841145 |
| 116 | MP0005000_abnormal_immune_tolerance | 0.96830006 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.96552860 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.96519226 |
| 119 | MP0005025_abnormal_response_to | 0.96063159 |
| 120 | MP0005671_abnormal_response_to | 0.94557593 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.94507389 |
| 122 | MP0001119_abnormal_female_reproductive | 0.94208279 |
| 123 | MP0005620_abnormal_muscle_contractility | 0.92917975 |
| 124 | MP0002108_abnormal_muscle_morphology | 0.92757973 |
| 125 | MP0002063_abnormal_learning/memory/cond | 0.92559866 |
| 126 | MP0005166_decreased_susceptibility_to | 0.92015678 |
| 127 | MP0003329_amyloid_beta_deposits | 0.91817770 |
| 128 | MP0005387_immune_system_phenotype | 0.91610071 |
| 129 | MP0001790_abnormal_immune_system | 0.91610071 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.91247643 |
| 131 | MP0000733_abnormal_muscle_development | 0.87379893 |
| 132 | MP0005083_abnormal_biliary_tract | 0.87378337 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.86783184 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.86395185 |
| 135 | MP0003633_abnormal_nervous_system | 0.85566884 |
| 136 | MP0003075_altered_response_to | 0.85210356 |
| 137 | MP0009763_increased_sensitivity_to | 0.84974804 |
| 138 | MP0000920_abnormal_myelination | 0.84782141 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.83828169 |
| 140 | MP0002272_abnormal_nervous_system | 0.83706833 |
| 141 | MP0003635_abnormal_synaptic_transmissio | 0.83464602 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.82177351 |
| 143 | MP0001905_abnormal_dopamine_level | 0.81859231 |
| 144 | MP0005332_abnormal_amino_acid | 0.81756423 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.81686763 |
| 146 | MP0006082_CNS_inflammation | 0.81569766 |
| 147 | MP0003011_delayed_dark_adaptation | 0.81250355 |
| 148 | MP0005319_abnormal_enzyme/_coenzyme | 0.81151191 |
| 149 | MP0001756_abnormal_urination | 0.79329384 |
| 150 | MP0001958_emphysema | 0.79005533 |
| 151 | MP0004019_abnormal_vitamin_homeostasis | 0.78839363 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.77975716 |
| 153 | MP0002972_abnormal_cardiac_muscle | 0.77570808 |
| 154 | MP0000747_muscle_weakness | 0.77439149 |
| 155 | MP0008469_abnormal_protein_level | 0.75175025 |
| 156 | MP0003693_abnormal_embryo_hatching | 0.74809954 |
| 157 | MP0001968_abnormal_touch/_nociception | 0.74277525 |
| 158 | MP0003137_abnormal_impulse_conducting | 0.74236651 |
| 159 | MP0001873_stomach_inflammation | 0.74142441 |
| 160 | MP0006138_congestive_heart_failure | 0.73228816 |
| 161 | MP0004885_abnormal_endolymph | 0.73137787 |
| 162 | MP0005646_abnormal_pituitary_gland | 0.73057224 |
| 163 | MP0002572_abnormal_emotion/affect_behav | 0.73004451 |
| 164 | MP0002168_other_aberrant_phenotype | 0.72371375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Male infertility (HP:0003251) | 4.95310828 |
| 2 | Deep venous thrombosis (HP:0002625) | 3.60401286 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 3.56956606 |
| 4 | Abnormal gallbladder physiology (HP:0012438) | 3.56329337 |
| 5 | Cholecystitis (HP:0001082) | 3.56329337 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.50274024 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 3.25482249 |
| 8 | Muscle fiber splitting (HP:0003555) | 3.17343095 |
| 9 | Prolonged bleeding time (HP:0003010) | 3.09437955 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00627317 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.00627317 |
| 12 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.98728283 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.89357376 |
| 14 | Spondylolisthesis (HP:0003302) | 2.78243683 |
| 15 | Dysostosis multiplex (HP:0000943) | 2.76307489 |
| 16 | J-shaped sella turcica (HP:0002680) | 2.73068120 |
| 17 | Lymphangioma (HP:0100764) | 2.72288639 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.71738225 |
| 19 | Subaortic stenosis (HP:0001682) | 2.71738225 |
| 20 | Increased CSF protein (HP:0002922) | 2.70594167 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69213289 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.68933989 |
| 23 | Colitis (HP:0002583) | 2.67102850 |
| 24 | Myositis (HP:0100614) | 2.66155717 |
| 25 | Complement deficiency (HP:0004431) | 2.65195640 |
| 26 | Testicular neoplasm (HP:0010788) | 2.64720587 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 2.64050782 |
| 28 | Cholelithiasis (HP:0001081) | 2.60890294 |
| 29 | Ventricular fibrillation (HP:0001663) | 2.60747904 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 2.60510760 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.56429909 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 2.55281792 |
| 33 | Polycythemia (HP:0001901) | 2.54186804 |
| 34 | Bundle branch block (HP:0011710) | 2.50891177 |
| 35 | Hamartoma of the eye (HP:0010568) | 2.49506577 |
| 36 | Achilles tendon contracture (HP:0001771) | 2.49335756 |
| 37 | Myopathic facies (HP:0002058) | 2.48426782 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.47378404 |
| 39 | Impaired platelet aggregation (HP:0003540) | 2.47331427 |
| 40 | Abnormal platelet function (HP:0011869) | 2.47331427 |
| 41 | Ventricular tachycardia (HP:0004756) | 2.46960781 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46484642 |
| 43 | Hyperthyroidism (HP:0000836) | 2.44207536 |
| 44 | Myoglobinuria (HP:0002913) | 2.43903586 |
| 45 | Muscle fiber inclusion bodies (HP:0100299) | 2.43681503 |
| 46 | Hypochromic anemia (HP:0001931) | 2.41603218 |
| 47 | Late onset (HP:0003584) | 2.40703117 |
| 48 | Ventricular arrhythmia (HP:0004308) | 2.40336458 |
| 49 | Conjunctival hamartoma (HP:0100780) | 2.39877320 |
| 50 | Exercise-induced muscle cramps (HP:0003710) | 2.38663547 |
| 51 | Viral hepatitis (HP:0006562) | 2.38379485 |
| 52 | Prolonged QT interval (HP:0001657) | 2.38007231 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.37480265 |
| 54 | Abnormal EKG (HP:0003115) | 2.34483706 |
| 55 | EMG: myopathic abnormalities (HP:0003458) | 2.34423761 |
| 56 | Exercise-induced myalgia (HP:0003738) | 2.34101900 |
| 57 | Myocardial infarction (HP:0001658) | 2.32907508 |
| 58 | Thrombocytosis (HP:0001894) | 2.31904587 |
| 59 | Nemaline bodies (HP:0003798) | 2.31057734 |
| 60 | Stomatitis (HP:0010280) | 2.30247805 |
| 61 | Enlarged penis (HP:0000040) | 2.28483043 |
| 62 | Microcytic anemia (HP:0001935) | 2.28080463 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.27447076 |
| 64 | Stridor (HP:0010307) | 2.27070102 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25633150 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.24531340 |
| 67 | Myotonia (HP:0002486) | 2.23860578 |
| 68 | Ankle clonus (HP:0011448) | 2.23632096 |
| 69 | Subacute progressive viral hepatitis (HP:0006572) | 2.23561247 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.22103133 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.21178022 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.20839930 |
| 73 | Hyperglycemia (HP:0003074) | 2.17500313 |
| 74 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16982563 |
| 75 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.15935116 |
| 76 | Easy fatigability (HP:0003388) | 2.15923959 |
| 77 | Syncope (HP:0001279) | 2.15898176 |
| 78 | Hematochezia (HP:0002573) | 2.14580083 |
| 79 | Round ear (HP:0100830) | 2.14045407 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.13743498 |
| 81 | IgM deficiency (HP:0002850) | 2.13654636 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.13543780 |
| 83 | Epistaxis (HP:0000421) | 2.11498540 |
| 84 | Akinesia (HP:0002304) | 2.10837940 |
| 85 | Ketosis (HP:0001946) | 2.10001673 |
| 86 | Fetal akinesia sequence (HP:0001989) | 2.08680813 |
| 87 | Hypercortisolism (HP:0001578) | 2.08666815 |
| 88 | Inflammation of the large intestine (HP:0002037) | 2.08585763 |
| 89 | Nasal polyposis (HP:0100582) | 2.08054604 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 2.06779020 |
| 91 | Cellulitis (HP:0100658) | 2.06628350 |
| 92 | Depressed nasal tip (HP:0000437) | 2.06015906 |
| 93 | Reticulocytosis (HP:0001923) | 2.05986755 |
| 94 | Atrioventricular block (HP:0001678) | 2.05302292 |
| 95 | Bone cyst (HP:0012062) | 2.05296836 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05103945 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05103945 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05103945 |
| 99 | Increased serum ferritin (HP:0003281) | 2.04840625 |
| 100 | Cerebral aneurysm (HP:0004944) | 2.04556050 |
| 101 | Abnormality of the nasal mucosa (HP:0000433) | 2.04483485 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.04357453 |
| 103 | Frequent falls (HP:0002359) | 2.04278779 |
| 104 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.03378722 |
| 105 | Abnormality of binocular vision (HP:0011514) | 2.03065924 |
| 106 | Diplopia (HP:0000651) | 2.03065924 |
| 107 | Abnormality of complement system (HP:0005339) | 2.02375494 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 2.00596842 |
| 109 | Oligomenorrhea (HP:0000876) | 2.00199119 |
| 110 | Febrile seizures (HP:0002373) | 1.98726911 |
| 111 | Acute myeloid leukemia (HP:0004808) | 1.98212874 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.96853448 |
| 113 | Arterial tortuosity (HP:0005116) | 1.95768979 |
| 114 | Axonal loss (HP:0003447) | 1.95363017 |
| 115 | Fatigue (HP:0012378) | 1.94966717 |
| 116 | Pustule (HP:0200039) | 1.93970216 |
| 117 | Ketoacidosis (HP:0001993) | 1.93635286 |
| 118 | Chest pain (HP:0100749) | 1.92428061 |
| 119 | Difficulty running (HP:0009046) | 1.91988018 |
| 120 | Macroorchidism (HP:0000053) | 1.91433680 |
| 121 | Malnutrition (HP:0004395) | 1.91296415 |
| 122 | Hyperammonemia (HP:0001987) | 1.91295667 |
| 123 | Albinism (HP:0001022) | 1.90279140 |
| 124 | Muscle fiber atrophy (HP:0100295) | 1.89414634 |
| 125 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89216444 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86435454 |
| 127 | Bulbar palsy (HP:0001283) | 1.86379075 |
| 128 | Aplastic anemia (HP:0001915) | 1.85489867 |
| 129 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84353598 |
| 130 | Hyperphosphatemia (HP:0002905) | 1.83635477 |
| 131 | Hyperkalemia (HP:0002153) | 1.83128667 |
| 132 | Lip pit (HP:0100267) | 1.82859280 |
| 133 | Hepatocellular carcinoma (HP:0001402) | 1.81873442 |
| 134 | Visceral angiomatosis (HP:0100761) | 1.81379168 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.81370171 |
| 136 | Lipoatrophy (HP:0100578) | 1.80958346 |
| 137 | Xanthomatosis (HP:0000991) | 1.80620957 |
| 138 | Rhabdomyolysis (HP:0003201) | 1.80498157 |
| 139 | Popliteal pterygium (HP:0009756) | 1.80123049 |
| 140 | Camptodactyly of toe (HP:0001836) | 1.80070894 |
| 141 | Ulnar deviation of the wrist (HP:0003049) | 1.79452368 |
| 142 | Neck muscle weakness (HP:0000467) | 1.79224942 |
| 143 | Hyperbilirubinemia (HP:0002904) | 1.79180060 |
| 144 | Acanthosis nigricans (HP:0000956) | 1.78988221 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78838216 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.78813858 |
| 147 | Poikilocytosis (HP:0004447) | 1.78717048 |
| 148 | Polar cataract (HP:0010696) | 1.78715035 |
| 149 | Intention tremor (HP:0002080) | 1.78682320 |
| 150 | Abnormality of the calf musculature (HP:0001430) | 1.78557753 |
| 151 | Sudden death (HP:0001699) | 1.78372819 |
| 152 | Large for gestational age (HP:0001520) | 1.78073490 |
| 153 | Supranuclear gaze palsy (HP:0000605) | 1.76816574 |
| 154 | EMG: neuropathic changes (HP:0003445) | 1.76693670 |
| 155 | Recurrent viral infections (HP:0004429) | 1.76494597 |
| 156 | Mesangial abnormality (HP:0001966) | 1.76324170 |
| 157 | Heart block (HP:0012722) | 1.74998560 |
| 158 | Recurrent skin infections (HP:0001581) | 1.74477121 |
| 159 | Calf muscle hypertrophy (HP:0008981) | 1.74133145 |
| 160 | Growth hormone excess (HP:0000845) | 1.73914397 |
| 161 | Hypoalphalipoproteinemia (HP:0003233) | 1.73689936 |
| 162 | Genu recurvatum (HP:0002816) | 1.73539295 |
| 163 | Sensorimotor neuropathy (HP:0007141) | 1.73506836 |
| 164 | Acne (HP:0001061) | 1.73158939 |
| 165 | Nonprogressive disorder (HP:0003680) | 1.72523633 |
| 166 | Peritonitis (HP:0002586) | 1.72151947 |
| 167 | Joint hemorrhage (HP:0005261) | 1.72019915 |
| 168 | Sudden cardiac death (HP:0001645) | 1.71723971 |
| 169 | Urethral obstruction (HP:0000796) | 1.70647876 |
| 170 | Lower limb asymmetry (HP:0100559) | 1.70316598 |
| 171 | Gastrointestinal stroma tumor (HP:0100723) | 1.69092631 |
| 172 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.67882897 |
| 173 | Broad face (HP:0000283) | 1.65555093 |
| 174 | Eczematoid dermatitis (HP:0000976) | 1.64952453 |
| 175 | Papilledema (HP:0001085) | 1.64594644 |
| 176 | Emphysema (HP:0002097) | 1.63953898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.44631757 |
| 2 | MAP3K6 | 3.56919681 |
| 3 | TRIB3 | 3.56469958 |
| 4 | FRK | 3.52040135 |
| 5 | FGFR2 | 2.97063715 |
| 6 | PKN2 | 2.69773935 |
| 7 | TAOK3 | 2.67083530 |
| 8 | KSR2 | 2.58295185 |
| 9 | MUSK | 2.57373851 |
| 10 | MAP3K10 | 2.53003641 |
| 11 | LATS1 | 2.43661816 |
| 12 | NTRK3 | 2.38247319 |
| 13 | BCKDK | 2.37910021 |
| 14 | TNK2 | 2.29329272 |
| 15 | MAP4K1 | 2.21854009 |
| 16 | FLT3 | 2.20559494 |
| 17 | MAPKAPK3 | 2.16699497 |
| 18 | PHKG2 | 2.13624626 |
| 19 | PHKG1 | 2.13624626 |
| 20 | KIT | 2.11774903 |
| 21 | ICK | 1.95309331 |
| 22 | MOS | 1.91062456 |
| 23 | MAP3K13 | 1.88263541 |
| 24 | ERN1 | 1.83991836 |
| 25 | LATS2 | 1.81744736 |
| 26 | MAP3K2 | 1.78934146 |
| 27 | TAOK1 | 1.71192248 |
| 28 | DAPK2 | 1.63853724 |
| 29 | FGFR3 | 1.61760206 |
| 30 | RAF1 | 1.55492392 |
| 31 | CDK8 | 1.54507358 |
| 32 | TTN | 1.50978654 |
| 33 | DMPK | 1.48508381 |
| 34 | MAP2K6 | 1.44219185 |
| 35 | CSF1R | 1.43766292 |
| 36 | PRPF4B | 1.43442467 |
| 37 | TYK2 | 1.40958803 |
| 38 | PRKCH | 1.39370225 |
| 39 | MAP3K9 | 1.37245714 |
| 40 | STK24 | 1.29881564 |
| 41 | MAP3K3 | 1.28210880 |
| 42 | CAMK1 | 1.25489838 |
| 43 | JAK3 | 1.22746335 |
| 44 | EPHA4 | 1.19854495 |
| 45 | STK10 | 1.14923728 |
| 46 | MAPK11 | 1.13490294 |
| 47 | ERBB4 | 1.13388572 |
| 48 | PINK1 | 1.04150186 |
| 49 | STK11 | 1.01491045 |
| 50 | RET | 1.00877879 |
| 51 | RPS6KB2 | 1.00496788 |
| 52 | TRPM7 | 1.00007258 |
| 53 | CAMK4 | 0.98796414 |
| 54 | TXK | 0.98579566 |
| 55 | MAP3K7 | 0.97088702 |
| 56 | CDK9 | 0.96459885 |
| 57 | MAP3K1 | 0.95285335 |
| 58 | SGK2 | 0.94905207 |
| 59 | CAMKK1 | 0.93931506 |
| 60 | CDC42BPA | 0.90636200 |
| 61 | PDPK1 | 0.89978814 |
| 62 | GRK6 | 0.87901465 |
| 63 | SGK3 | 0.87819117 |
| 64 | PRKD2 | 0.87698152 |
| 65 | BTK | 0.87554217 |
| 66 | SGK494 | 0.87476086 |
| 67 | SGK223 | 0.87476086 |
| 68 | MAP2K3 | 0.85376067 |
| 69 | JAK2 | 0.84777052 |
| 70 | RPS6KA2 | 0.84332673 |
| 71 | RPS6KC1 | 0.83075387 |
| 72 | RPS6KL1 | 0.83075387 |
| 73 | PTK6 | 0.82009305 |
| 74 | MAPK7 | 0.80949365 |
| 75 | ABL2 | 0.79969481 |
| 76 | RIPK1 | 0.79112472 |
| 77 | SIK1 | 0.78991098 |
| 78 | TTK | 0.78756141 |
| 79 | LRRK2 | 0.77191311 |
| 80 | PRKAA2 | 0.76165038 |
| 81 | MYLK | 0.74839777 |
| 82 | RPS6KA6 | 0.74657008 |
| 83 | HIPK2 | 0.74577332 |
| 84 | MAP3K8 | 0.73137508 |
| 85 | PRKD1 | 0.71782213 |
| 86 | MAPK12 | 0.70514252 |
| 87 | MAP2K2 | 0.70476065 |
| 88 | STK3 | 0.70192144 |
| 89 | TGFBR2 | 0.69052389 |
| 90 | MAP2K1 | 0.67237870 |
| 91 | PIK3CA | 0.66527198 |
| 92 | PRKCZ | 0.65928808 |
| 93 | SIK2 | 0.65794945 |
| 94 | WNK4 | 0.65683266 |
| 95 | STK38 | 0.64959632 |
| 96 | PRKD3 | 0.64410489 |
| 97 | MATK | 0.63738083 |
| 98 | DAPK1 | 0.63281572 |
| 99 | NEK2 | 0.63204787 |
| 100 | MAP3K11 | 0.62528889 |
| 101 | MAPK15 | 0.62036829 |
| 102 | MARK2 | 0.61847941 |
| 103 | ZAP70 | 0.61757124 |
| 104 | CAMK2G | 0.61525330 |
| 105 | PIK3CG | 0.61194427 |
| 106 | NTRK2 | 0.60431406 |
| 107 | EPHA2 | 0.59969579 |
| 108 | PLK4 | 0.59772874 |
| 109 | PAK3 | 0.59606101 |
| 110 | RIPK4 | 0.59023146 |
| 111 | CAMK2D | 0.57977889 |
| 112 | ARAF | 0.57166730 |
| 113 | EPHB1 | 0.56752738 |
| 114 | AKT3 | 0.56381211 |
| 115 | CDC7 | 0.55516187 |
| 116 | PRKCQ | 0.55229734 |
| 117 | IKBKB | 0.54967484 |
| 118 | ROCK1 | 0.54247558 |
| 119 | TBK1 | 0.54053693 |
| 120 | MAPKAPK5 | 0.53872983 |
| 121 | FGFR4 | 0.53795466 |
| 122 | MELK | 0.53300609 |
| 123 | PAK6 | 0.53037219 |
| 124 | MAPK4 | 0.50600885 |
| 125 | CAMK1D | 0.49913235 |
| 126 | PKN1 | 0.49448466 |
| 127 | PIM1 | 0.49252931 |
| 128 | PRKAA1 | 0.47942826 |
| 129 | JAK1 | 0.47504568 |
| 130 | NLK | 0.47475540 |
| 131 | GRK5 | 0.47327905 |
| 132 | CHUK | 0.47237027 |
| 133 | IKBKE | 0.46975553 |
| 134 | STK38L | 0.46459327 |
| 135 | PDGFRA | 0.46381794 |
| 136 | ITK | 0.44913263 |
| 137 | LCK | 0.43344401 |
| 138 | TGFBR1 | 0.43148953 |
| 139 | ILK | 0.42634156 |
| 140 | CSK | 0.40083308 |
| 141 | HCK | 0.39376549 |
| 142 | CDK7 | 0.38213648 |
| 143 | TYRO3 | 0.38077324 |
| 144 | STK4 | 0.37230007 |
| 145 | CDK4 | 0.36142606 |
| 146 | TEC | 0.35435667 |
| 147 | FES | 0.35037021 |
| 148 | PDK1 | 0.34706464 |
| 149 | BRAF | 0.33811144 |
| 150 | SCYL2 | 0.29537145 |
| 151 | ABL1 | 0.29397014 |
| 152 | OBSCN | 0.27533474 |
| 153 | SYK | 0.27137244 |
| 154 | PAK4 | 0.27070586 |
| 155 | RPS6KA1 | 0.26438525 |
| 156 | DYRK2 | 0.26393143 |
| 157 | MTOR | 0.25376948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.13369494 |
| 2 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.10917048 |
| 3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.10170028 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.06757183 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.00534152 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.99306124 |
| 7 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.94011387 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.84986411 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78381510 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.77230278 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74268114 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72909916 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71482006 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71215690 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69216201 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62463318 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60604199 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.50059197 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48931526 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.45939127 |
| 21 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.45451412 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.43849325 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.43006462 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.42246467 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40819052 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38201518 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.36844898 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34025336 |
| 29 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.33182067 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32419239 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28701385 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27826594 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27163326 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.26139687 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.25301574 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25179862 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.24278641 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.23944130 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22807545 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22283385 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.21705152 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18646209 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16915820 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16657249 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.16610800 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 1.16263239 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15537250 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.13946015 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13437889 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13107110 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12592025 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.12197707 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11272882 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10924143 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10392760 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09919436 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09727894 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09502818 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09364355 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08441823 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06479437 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05230088 |
| 63 | Glioma_Homo sapiens_hsa05214 | 1.05089314 |
| 64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03863204 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03203796 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03037599 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.02695966 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02408340 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02289953 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02146427 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01876163 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 1.00443958 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99603561 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99087616 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.98709434 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98626059 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.97570409 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96879614 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95822678 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.94368326 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94168260 |
| 82 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.92650245 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92455569 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92029048 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91434158 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90736444 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89921700 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89289747 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88798451 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.86526579 |
| 91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84555389 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84261318 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83640950 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.81965468 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81539539 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81140569 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81077698 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80839486 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80159759 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80109241 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79335329 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78700642 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77821314 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77309548 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.77096536 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77006892 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76331364 |
| 108 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76050204 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74679075 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.74611180 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72209052 |
| 112 | DNA replication_Homo sapiens_hsa03030 | 0.71328201 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.70639861 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69505440 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.68973870 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68889852 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68453769 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68440800 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68168999 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67497626 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66535104 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65943196 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64961814 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63652495 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63359151 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62683418 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62246345 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.61869832 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61672353 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60944661 |
| 131 | Base excision repair_Homo sapiens_hsa03410 | 0.60523442 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60494485 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59627160 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.59027431 |
| 135 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58913878 |
| 136 | Measles_Homo sapiens_hsa05162 | 0.58827566 |
| 137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58607164 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58568528 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56800531 |
| 140 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56481575 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56330196 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55733277 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55621317 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54848882 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54821784 |
| 146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54188169 |
| 147 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53596331 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52141292 |
| 149 | Pertussis_Homo sapiens_hsa05133 | 0.52070616 |
| 150 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51680271 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51105015 |
| 152 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50300040 |
| 153 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49698124 |
| 154 | Asthma_Homo sapiens_hsa05310 | 0.49424356 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49163747 |
| 156 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47821294 |
| 157 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47762426 |
| 158 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46946499 |
| 159 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46675661 |
| 160 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46663958 |
| 161 | Focal adhesion_Homo sapiens_hsa04510 | 0.46228612 |
| 162 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46200497 |
| 163 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46070849 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44293870 |

